Fox Kate L, Cox Andrew D, Gilbert Michel, Wakarchuk Warren W, Li Jianjun, Makepeace Katherine, Richards James C, Moxon E Richard, Hood Derek W
Molecular Infectious Diseases Group, University of Oxford Department of Paediatrics, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, United Kingdom.
J Biol Chem. 2006 Dec 29;281(52):40024-32. doi: 10.1074/jbc.M602314200. Epub 2006 Oct 27.
The lipopolysaccharide (LPS) of non-typeable Haemophilus influenzae (NTHi) can be substituted at various positions by N-acetylneuraminic acid (Neu5Ac). LPS sialylation plays an important role in pathogenesis. The only LPS sialyltransferase characterized biochemically to date in H. influenzae is Lic3A, an alpha-2,3-sialyltransferase responsible for the addition of Neu5Ac to a lactose acceptor (Hood, D. W., Cox, A. D., Gilbert, M., Makepeace, K., Walsh, S., Deadman, M. E., Cody, A., Martin, A., Månsson, M., Schweda, E. K., Brisson, J. R., Richards, J. C., Moxon, E. R., and Wakarchuk, W. W. (2001) Mol. Microbiol. 39, 341-350). Here we describe a second sialyltransferase, Lic3B, that is a close homologue of Lic3A and present in 60% of NTHi isolates tested. A recombinant form of Lic3B was expressed in Escherichia coli and purified by affinity chromatography. We used synthetic fluorescent acceptors with a terminal lactose or sialyllactose to show that Lic3B has both alpha-2,3- and alpha-2,8-sialyltransferase activities. Structural analysis of LPS from lic3B mutant strains of NTHi confirmed that only monosialylated species were detectable, whereas disialylated species were detected upon inactivation of lic3A. Furthermore, introduction of lic3B into a lic3B-deficient strain background resulted in a significant increase in sialylation in the recipient strain. Mass spectrometric analysis of LPS indicated that glycoforms containing two Neu5Ac residues were evident that were not present in the LPS of the parent strain. These findings characterize the activity of a second sialyltransferase in H. influenzae, responsible for the addition of di-sialic acid to the LPS. Modification of the LPS by di-sialylation conferred increased resistance of the organism to the killing effects of normal human serum, as compared with mono-sialylated or non-sialylated species, indicating that this modification has biological significance.
不可分型流感嗜血杆菌(NTHi)的脂多糖(LPS)可在不同位置被N - 乙酰神经氨酸(Neu5Ac)取代。LPS的唾液酸化在发病机制中起重要作用。迄今为止,在流感嗜血杆菌中唯一经生物化学鉴定的LPS唾液酸转移酶是Lic3A,一种α-2,3-唾液酸转移酶,负责将Neu5Ac添加到乳糖受体上(胡德,D. W.,考克斯,A. D.,吉尔伯特,M.,马克皮斯,K.,沃尔什,S.,迪德曼,M. E.,科迪,A.,马丁,A.,曼松,M.,施韦达,E. K.,布里松,J. R.,理查兹,J. C.,莫克森,E. R.,和瓦卡丘克,W. W.(2001年)《分子微生物学》39卷,341 - 350页)。在此,我们描述了第二种唾液酸转移酶Lic3B,它是Lic3A的紧密同源物,在所测试的60%的NTHi分离株中存在。Lic3B的重组形式在大肠杆菌中表达,并通过亲和层析纯化。我们使用带有末端乳糖或唾液酸乳糖的合成荧光受体来表明Lic3B具有α-2,3-和α-2,8-唾液酸转移酶活性。对NTHi的lic3B突变株的LPS进行结构分析证实,仅可检测到单唾液酸化物种,而在lic3A失活后可检测到双唾液酸化物种。此外,将lic3B导入lic3B缺陷株背景导致受体菌株中的唾液酸化显著增加。LPS的质谱分析表明,含有两个Neu5Ac残基的糖型明显,而亲本菌株的LPS中不存在这些糖型。这些发现表征了流感嗜血杆菌中第二种唾液酸转移酶的活性,该酶负责将二唾液酸添加到LPS上。与单唾液酸化或非唾液酸化物种相比,通过二唾液酸化对LPS进行修饰使该生物体对正常人血清的杀伤作用具有更高的抗性,表明这种修饰具有生物学意义。